Islet cell-specific autoantibodies as potential markers for recurrence of autoimmune type 1 diabetes after simultaneous pancreas-kidney transplantation

By Lohmann T.   Klemm T.   Geissler F.   Uhlmann D.   Ludwig S.   Hauss J.   Witzigmann H.  

Transplantation Proceedings, Vol. 34, Iss. 6, 2002-09 ,pp. : 2249-2250

Elsevier

Access to resources Recommend Favorite

Complement-Fixing Islet Cell Antibodies in Type-1 Diabetes Can Trigger the Assembly of the Terminal Complement Complex on Human Islet Cells and Are Potentially Cytotoxic

By Radillo O.   Nocera A.   Leprini A.   Barocci S.   Mollnes T.E.   Pocecco M.   Pausa M.   Valente U.   Betterle C.   Tedesco F.  

Clinical Immunology, Vol. 79, Iss. 3, 1996-06 ,pp. : 217-223

Academic Press

Access to resources Recommend Favorite

Interleukin-1β, Interleukin-1 Receptor Antagonist, and Soluble Interleukin-1 Receptor Type II Secretion in Chronic Fatigue Syndrome

By Cannon Joseph G.   Angel Jonathan B.   Abad Leslie W.   Vannier Edouard   Mileno Maria D.   Fagioli Laura   Wolff Sheldon M.   Komaroff Anthony L.  

Journal of Clinical Immunology, Vol. 17, Iss. 3, 1997-05 ,pp. : 253-261

Springer Publishing Company

Access to resources Recommend Favorite

Adeno-Associated Virus (AAV) as a Vehicle for Therapeutic Gene Delivery Improvements in Vector Design and Viral Production Enhance Potential to Prolong Graft Survival in Pancreatic Islet Cell Transplantation for the Reversal of Type 1 Diabetes.

By  

Current Molecular Medicine, Vol. 1, Iss. 2, 2001-05 ,pp. : 245-258

Bentham Science Publishers

Access to resources Recommend Favorite

Course of Islet Autoantibody Titers During Ig-immunoadsorption in a Patient with Newly Diagnosed Type 1 Diabetes

By Seidel D.K.     Donner M.G.   Ritter M.M.   Schwandt P.   Koll R.A.   Standl E.    

Journal of Autoimmunity, Vol. 11, Iss. 3, 1998-06 ,pp. : 273-277

Academic Press

Access to resources Recommend Favorite